Capricor Therapeutics, Inc.

{
  "main_header": {
    "sid": 1151853,
    "name": "Capricor Therapeutics, Inc.",
    "stock_name": "Capricor Therapeutics, Inc.",
    "full_name": "Capricor Therapeutics, Inc.",
    "name_url": "stocks-analysis/capricor-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "24.50",
    "chg": -0.38,
    "chgp": "-1.53%",
    "dir": -1,
    "prev_price": "24.88",
    "mcapval": "1,322.48",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US14070B3096",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "546.11 k",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/capricor-therapeutics-inc-1151853-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Capricor Therapeutics Hits New 52-Week Low at $4.40 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/capricor-therapeutics-hits-new-52-week-low-at-440-amid-financial-struggles-3729421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CapricorTherape_priceRelatedfactors_3729421.png",
        "date": "2025-11-25 16:23:00",
        "description": "Capricor Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance. The company reported a 46.91% drop in net sales for the first nine months, alongside a negative operating cash flow and rising raw material costs, indicating ongoing financial challenges."
      },
      {
        "title": "Capricor Therapeutics Hits 52-Week Low at $5.43 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/capricor-therapeutics-hits-52-week-low-at-543-amid-financial-struggles-3690319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CapricorTherape_priceRelatedfactors_3690319.png",
        "date": "2025-11-11 18:07:12",
        "description": "Capricor Therapeutics, Inc. has hit a new 52-week low, reflecting a significant decline in its stock value over the past year. The company reported a 46.91% drop in net sales and a negative operating cash flow, compounded by rising raw material costs. Its financial metrics indicate ongoing challenges."
      }
    ],
    "total": 9,
    "sid": "1151853",
    "stock_news_url": "https://www.marketsmojo.com/news/capricor-therapeutics-inc-1151853"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Capricor Therapeutics Hits New 52-Week Low at $4.40 Amid Financial Struggles

2025-11-25 16:23:00

Capricor Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance. The company reported a 46.91% drop in net sales for the first nine months, alongside a negative operating cash flow and rising raw material costs, indicating ongoing financial challenges.

Read full news article

Capricor Therapeutics Hits 52-Week Low at $5.43 Amid Financial Struggles

2025-11-11 18:07:12

Capricor Therapeutics, Inc. has hit a new 52-week low, reflecting a significant decline in its stock value over the past year. The company reported a 46.91% drop in net sales and a negative operating cash flow, compounded by rising raw material costs. Its financial metrics indicate ongoing challenges.

Read full news article

View All News